Science Explorer Back to mapMap
Discussion
Researcher · 3D-Micromac (Germany) · Germany

Ralf Lutterbuese

Ralf Lutterbuese publishes mostly in Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research and Immunotherapy and Immune Responses.

OpenAlex
World rank
#825,114
of 7,710,434 ranked researchers
Rank in Germany
#40,561
of 364,343
Works
37
Citations
2.1k
Citations per work
55.5
h-index
11
i10-index 11Top 50% in Radiology, Nuclear Medicine and Imaging
Ralf Lutterbuese

What does Ralf Lutterbuese research?

Ralf Lutterbuese's work is mostly in Medicine (67%), Immunology and Microbiology (14%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 25 works · 66.6% of their workMedicine: 25 works · 66.6% of their workRadiology, Nuclear Medicine and Imaging: 14 works · 36.8% of their workOncology: 11 works · 29.8% of their workLife Sciences: 9 works · 24.6% of their workImmunology and Microbiology: 5 works · 14.0% of their workImmunology: 5 works · 14.0% of their workBiochemistry, Genetics and Molecular Biology: 4 works · 10.6% of their workMolecular Biology: 3 works · 7.0% of their workBiotechnology: 1 works · 1.8% of their workCancer Research: 1 works · 1.8% of their workEverything else: 3 works · 8.8% of their workTHEIR WORKRalf Lutterbuese37works
Life Sciences25%Health Sciences67%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2566.6%
    1. Immunology and Microbiology514.0%
    2. Biochemistry, Genetics and Molecular Biology410.6%
  3. Everything else38.8%
  1. 1Radiology, Nuclear Medicine and Imaging37% of their works
  2. 2Oncology30% of their works
  3. 3Immunology14% of their works
  4. 4Molecular Biology7% of their works
  5. 5Biotechnology2% of their works
  6. 6Cancer Research2% of their works

Research topics

Which keywords describe Ralf Lutterbuese's research?

The keywords of their largest research topics: Glycosylation, Cancer Immunotherapy, Fc Receptors, Therapeutic Antibodies, Immunotherapy, Tumor Regression, CAR T Cells and Chimeric Antigen Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Glycosylation192 topics
  2. Cancer Immunotherapy182 topics
  3. Fc Receptors181 topic
  4. Therapeutic Antibodies181 topic
  5. Immunotherapy132 topics
  6. Tumor Regression132 topics
  7. CAR T Cells121 topic
  8. Chimeric Antigen Receptor121 topic
  9. Dendritic Cells61 topic
  10. Immunity61 topic
  11. Targeted Therapy42 topics
  12. PET Imaging31 topic
  13. Radiopharmaceuticals31 topic
  14. Immune Checkpoint Blockade21 topic
  15. PD-1 and PD-L121 topic
  16. Bacterial Therapy11 topic
  17. Cancer11 topic
  18. Cancer Genomics11 topic
  19. Glycans11 topic
  20. Mutational Signatures11 topic
  21. Tumor Targeting11 topic

Where does Ralf Lutterbuese work?

Ralf Lutterbuese's main affiliation in the publication record is 3D-Micromac (Germany), Germany.

How many publications and citations does Ralf Lutterbuese have?

OpenAlex counts 37 works and 2,053 citations for Ralf Lutterbuese, an h-index of 11, ranking #825,114 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Ralf Lutterbuese. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.